143 related articles for article (PubMed ID: 6276966)
1. Hyperplastic lesions of the human breast: scanning electron microscopy and a review of current knowledge.
Halter SA; Holt DH; Page DL
Scan Electron Microsc; 1981; (Pt 3):11-21. PubMed ID: 6276966
[TBL] [Abstract][Full Text] [Related]
2. Characterization by image cytometry of duct epithelial proliferative disease of the breast.
King EB; Chew KL; Hom JD; Duarte LA; Mayall B; Miller TR; Neuhaus JM; Wrensch MR; Petrakis NL
Mod Pathol; 1991 May; 4(3):291-6. PubMed ID: 1712475
[TBL] [Abstract][Full Text] [Related]
3. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
[No Abstract] [Full Text] [Related]
4. [Morphology of dysplasia and small cancer of the breast].
Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
[TBL] [Abstract][Full Text] [Related]
5. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?
Ellis IO; Pinder SE; Lee AH; Elston CW
Semin Diagn Pathol; 1999 Aug; 16(3):202-8. PubMed ID: 10490197
[TBL] [Abstract][Full Text] [Related]
6. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
7. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
8. Diseases of the human breast: selective isolation and exposure of epithelia and their correlative surface features and histopathology.
Bradbury E; Mithcell WM
Scan Electron Microsc; 1979; (3):139-52. PubMed ID: 230574
[TBL] [Abstract][Full Text] [Related]
9. [Whole organ giant section histopathologic studies on breast cancer. III. Benign lesions in cancerous breast and near the tumor areas].
Zhang ZD
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):20-2. PubMed ID: 8392928
[TBL] [Abstract][Full Text] [Related]
10. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
11. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
[TBL] [Abstract][Full Text] [Related]
12. Pathology of high-risk breast lesions and ductal carcinoma in situ.
Sewell CW
Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
[TBL] [Abstract][Full Text] [Related]
13. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
14. [Symptomology of non-invasive proliferative epithelial changes in the breast].
Geppert M; Bachmann FF
Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
[No Abstract] [Full Text] [Related]
15. Histopathologic risk factors for breast cancer in women with benign breast disease.
Page DL; Dupont WD
Semin Surg Oncol; 1988; 4(4):213-7. PubMed ID: 2854655
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer in a patient with prolactinoma.
Theodorakis SP; Tedesco VE; Sutherland CM
Surgery; 1985 Aug; 98(2):367-9. PubMed ID: 2992109
[TBL] [Abstract][Full Text] [Related]
17. Papillary lesions of the breast.
Ibarra JA
Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
[TBL] [Abstract][Full Text] [Related]
18. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
Carder PJ; Garvican J; Haigh I; Liston JC
Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
[TBL] [Abstract][Full Text] [Related]
19. Pathologic considerations in the high-risk breast patient.
Simmons R; Serafin D; McCarty K
Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
[TBL] [Abstract][Full Text] [Related]
20. [Cytological changes in breast carcinoma in situ].
Stosiek U; Breitbach GP
Zentralbl Gynakol; 1984; 106(6):407-10. PubMed ID: 6326431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
